The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-{5-Chloro-6-[(1R)-1-(5-methylpyridin-2-yl)ethoxy]-2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl}propanoic Acid tris(hydroxymethyl)aminomethane salt ID: ALA4099039
PubChem CID: 137660909
Max Phase: Preclinical
Molecular Formula: C22H28ClN3O8
Molecular Weight: 376.80
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc([C@@H](C)Oc2cc3oc(=O)n(CCC(=O)O)c3cc2Cl)nc1.NC(CO)(CO)CO
Standard InChI: InChI=1S/C18H17ClN2O5.C4H11NO3/c1-10-3-4-13(20-9-10)11(2)25-15-8-16-14(7-12(15)19)21(18(24)26-16)6-5-17(22)23;5-4(1-6,2-7)3-8/h3-4,7-9,11H,5-6H2,1-2H3,(H,22,23);6-8H,1-3,5H2/t11-;/m1./s1
Standard InChI Key: SPSZMEXSTPMSDY-RFVHGSKJSA-N
Molfile:
RDKit 2D
34 35 0 0 0 0 0 0 0 0999 V2000
6.4928 -6.8999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0884 -7.6098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9054 -7.6052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0904 -8.4342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3813 -7.2043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6722 -7.6129 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3180 -8.3105 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0802 -6.1946 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0981 -8.1580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8849 -7.3626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0905 -7.1454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5128 -8.7404 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8924 -8.3710 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8387 -5.0251 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3218 -5.6959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8354 -6.3601 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0514 -6.1053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0534 -5.2803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3345 -6.5160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6238 -6.1018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6216 -5.2768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3385 -4.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1468 -5.6980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9110 -4.8625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1941 -5.2774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1921 -6.1024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4793 -4.8631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4813 -4.0381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7707 -3.6239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0538 -4.0345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0518 -4.8595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7666 -5.2738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9069 -6.5125 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.3406 -3.6200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
2 4 1 0
5 6 1 0
2 5 1 0
3 7 1 0
1 8 1 0
9 10 1 0
10 11 1 0
9 12 2 0
9 13 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
14 18 1 0
19 20 1 0
20 21 2 0
21 22 1 0
18 22 2 0
17 19 2 0
15 23 2 0
25 26 1 6
24 25 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
27 32 2 0
25 27 1 0
21 24 1 0
20 33 1 0
11 16 1 0
30 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 376.80Molecular Weight (Monoisotopic): 376.0826AlogP: 3.57#Rotatable Bonds: 6Polar Surface Area: 94.56Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.13CX Basic pKa: 4.24CX LogP: 1.83CX LogD: -0.41Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.71Np Likeness Score: -1.15
References 1. Walker AL, Ancellin N, Beaufils B, Bergeal M, Binnie M, Bouillot A, Clapham D, Denis A, Haslam CP, Holmes DS, Hutchinson JP, Liddle J, McBride A, Mirguet O, Mowat CG, Rowland P, Tiberghien N, Trottet L, Uings I, Webster SP, Zheng X, Mole DJ.. (2017) Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis., 60 (8): [PMID:28398044 ] [10.1021/acs.jmedchem.7b00055 ]